

Advancements in HER2-Positive Breast Cancer Treatments and Survival Rates
HER2-positive breast cancer is an aggressive subtype characterized by the overexpression of the HER2 protein, affecting a considerable portion of breast cancer patients. Recent advancements in targeted therapies have dramatically enhanced treatment options and improved survival rates. From evolving treatments like trastuzumab and new medications such as tucatinib to promising clinical trials, knowledge of these […]
3 min read